News

Hosted by Horizon 3 Biotech Investment Committee Member Dr Tam Nguyen. In this episode Tam talks to Michelle Gallaher from Opyl and Dr Stefan Harrer

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Dr Megan Baldwin, CEO and Managing Director

More detail about what the Horizon 3 Fund is.

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by John Melki CEO of Genetic Signatures, Dr

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Dr Chris Baldwin, Deputy CEO and Chief

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Simon Davidson from Lander & Rogers and

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Rosemary Cummins of MST Financial and Ralph

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Tony Locantro from Alto Capital and Sue

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Investment Analyst Scott Power at Morgans to

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara Matt MacNamara, Chief Investment Officer at Horizon 3 Biotech &  Scott Power, Investment Committee at

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara Matt MacNamara, Chief Investment Officer at Horizon 3 Biotech &  Scott Power, Investment Committee at

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Chris Behrenbruch from Telix Pharmaceuticals and David

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Opthea CEO & Managing Director Dr Megan

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Horizon 3 Biotech Life Sciences and Capital

This Guide to Life Sciences Investing, with foreword from Horizon 3’s Board member Glenn Cross, will provide potential investors in life sciences companies with consolidated, factual,